AAAAAA

   
Results: 1-9 |
Results: 9
LOW RELATIVE FREQUENCIES OF CD26(-TERM NONPROGRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS() CD4(+) CELLS IN LONG)
Authors: BROSTROM C SONNERBORG A LINDBACK S GAINES H
Citation: C. Brostrom et al., LOW RELATIVE FREQUENCIES OF CD26(-TERM NONPROGRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS() CD4(+) CELLS IN LONG), Clinical and diagnostic laboratory immunology, 5(5), 1998, pp. 662-666
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DISEASE PROGRESSION, CCR5 GENOTYPE, AND SPECIFIC IMMUNE-RESPONSES
Authors: VISCOCOMANDINI U HULTGREN C BROSTROM C BIRK M KIM S SALLBERG M
Citation: U. Viscocomandini et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DISEASE PROGRESSION, CCR5 GENOTYPE, AND SPECIFIC IMMUNE-RESPONSES, Clinical and diagnostic laboratory immunology, 5(4), 1998, pp. 463-466
APOPTOSIS OF CD4(-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATION WITH CLINICAL PROGRESSION, VIRAL LOAD, AND LOSS OF HUMORAL IMMUNITY() AND CD19(+) CELLS DURING HUMAN)
Authors: SAMUELSSON A BROSTROM C VANDIJK N SONNERBORG A CHIODI F
Citation: A. Samuelsson et al., APOPTOSIS OF CD4(-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATION WITH CLINICAL PROGRESSION, VIRAL LOAD, AND LOSS OF HUMORAL IMMUNITY() AND CD19(+) CELLS DURING HUMAN), Virology, 238(2), 1997, pp. 180-188
SITE-DIRECTED SEROLOGY OF HIV-1 SUBTYPE-B INFECTION - RELATION BETWEEN VIRUS-SPECIFIC ANTIBODY-LEVELS AND DISEASE PROGRESSION
Authors: BROSTROM C SONNERBORG A KIM S SALLBERG M
Citation: C. Brostrom et al., SITE-DIRECTED SEROLOGY OF HIV-1 SUBTYPE-B INFECTION - RELATION BETWEEN VIRUS-SPECIFIC ANTIBODY-LEVELS AND DISEASE PROGRESSION, Clinical and experimental immunology, 106(1), 1996, pp. 35-39
ELEVATED SERUM LEVELS OF SOLUBLE FAS APO-1 IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS/
Authors: FADEEL B SAMUELSSON A HACHIYA T BROSTROM C CHIODI F
Citation: B. Fadeel et al., ELEVATED SERUM LEVELS OF SOLUBLE FAS APO-1 IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS/, Blood, 88(12), 1996, pp. 4727-4730
BIOLOGICAL AND MOLECULAR CHARACTERIZATION OF SUBTYPE-D, SUBTYPE-G, AND SUBTYPE-A D RECOMBINANT HIV-1 TRANSMISSIONS IN SWEDEN/
Authors: LEITNER T ESCANILLA D MARQUINA S WAHLBERG J BROSTROM C HANSSON HB UHLEN M ALBERT J
Citation: T. Leitner et al., BIOLOGICAL AND MOLECULAR CHARACTERIZATION OF SUBTYPE-D, SUBTYPE-G, AND SUBTYPE-A D RECOMBINANT HIV-1 TRANSMISSIONS IN SWEDEN/, Virology, 209(1), 1995, pp. 136-146
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS WITH NO DISEASEPROGRESSION DISPLAY HIGH-AVIDITY ANTIBODY-PRODUCTION TO AUTOLOGOUS V3SEQUENCES
Authors: BROSTROM C SONNERBORG A SALLBERG M
Citation: C. Brostrom et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS WITH NO DISEASEPROGRESSION DISPLAY HIGH-AVIDITY ANTIBODY-PRODUCTION TO AUTOLOGOUS V3SEQUENCES, The Journal of infectious diseases, 171(2), 1995, pp. 509-511
DOES SYMPTOMATIC PRIMARY HIV-1 INFECTION ACCELERATE PROGRESSION TO CDC STAGE-IV DISEASE, CD4 COUNT BELOW 200 X 10(6) 1, AIDS, AND DEATH FROM AIDS/
Authors: LINDBACK S BROSTROM C KARLSSON A GAINES H
Citation: S. Lindback et al., DOES SYMPTOMATIC PRIMARY HIV-1 INFECTION ACCELERATE PROGRESSION TO CDC STAGE-IV DISEASE, CD4 COUNT BELOW 200 X 10(6) 1, AIDS, AND DEATH FROM AIDS/, BMJ. British medical journal, 309(6968), 1994, pp. 1535-1537
CROSS-RESISTANCE BETWEEN AZT, DDL AND OTHER ANTIRETROVIRAL DRUGS IN PRIMARY ISOLATES OF HIV-1
Authors: COX SW APERIA K SANDSTROM E HOLMBERG V MORFELDTMANSON L BROSTROM C WAHREN B ALBERT J
Citation: Sw. Cox et al., CROSS-RESISTANCE BETWEEN AZT, DDL AND OTHER ANTIRETROVIRAL DRUGS IN PRIMARY ISOLATES OF HIV-1, Antiviral chemistry & chemotherapy, 5(1), 1994, pp. 7-12
Risultati: 1-9 |